C

Cipla Ltd

PharmaceuticalsMidcap

About the company

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Performance

Stock
Loading Stock value
—

Analyst Ratings and Key Metrics

Based on 35 analysts offering recommendations for Cipla Ltd

63%

Buy

29%

Hold

8%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio27.0944.80
PB Ratio3.045.62
Dividend Yield1.00%0.51%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions